{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:13:19Z","timestamp":1788955999158,"version":"build-2803163510"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Famous Physicians among the Ten Thousand Talents Program of Yunnan Province","award":["YNWR-MY-2019-023"],"award-info":[{"award-number":["YNWR-MY-2019-023"]}]},{"name":"the Open Project of Yunnan Clinical Medical Cente","award":["2022LCZXKF-XY10"],"award-info":[{"award-number":["2022LCZXKF-XY10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03962-0","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:06:22Z","timestamp":1759489582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cellular and molecular features of acute myeloid leukemia investigation based on single-cell RNA sequencing"],"prefix":"10.1186","volume":"25","author":[{"given":"Zheng-fa","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-rong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-jiao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-liu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-lu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ling","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"3962_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1195392","volume":"13","author":"Y Pan","year":"2023","unstructured":"Pan Y, et al. Aggrephagy-related patterns in tumor microenvironment, prognosis, and immunotherapy for acute myeloid leukemia: a comprehensive single-cell RNA sequencing analysis. Front Oncol. 2023;13:1195392.","journal-title":"Front Oncol"},{"issue":"1","key":"3962_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13045-020-00941-y","volume":"13","author":"J Wu","year":"2020","unstructured":"Wu J, et al. A single-cell survey of cellular hierarchy in acute myeloid leukemia. J Hematol Oncol. 2020;13(1):128.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"3962_CR3","first-page":"326","volume":"44","author":"SM Devine","year":"1994","unstructured":"Devine SM, Larson RA. Acute leukemia in adults: recent developments in diagnosis and treatment. CA Cancer J Clin. 1994;44(6):326\u201352.","journal-title":"CA Cancer J Clin"},{"issue":"9048","key":"3962_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S0140-6736(96)09412-3","volume":"349","author":"MF Greaves","year":"1997","unstructured":"Greaves MF. Aetiology of acute leukaemia. Lancet. 1997;349(9048):344\u20139.","journal-title":"Lancet"},{"issue":"6","key":"3962_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/bjh.15129","volume":"180","author":"A Gutierrez","year":"2018","unstructured":"Gutierrez A, Kentsis A. Acute myeloid\/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy. Br J Haematol. 2018;180(6):919\u201324.","journal-title":"Br J Haematol"},{"issue":"1","key":"3962_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","volume":"14","author":"H Liu","year":"2021","unstructured":"Liu H. Emerging agents and regimens for AML. J Hematol Oncol. 2021;14(1):49.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3962_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13402-023-00853-2","volume":"47","author":"X Hu","year":"2024","unstructured":"Hu X, et al. Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy. Cell Oncol (Dordr). 2024;47(1):97\u2013112.","journal-title":"Cell Oncol (Dordr)"},{"issue":"11","key":"3962_CR8","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1007\/s11864-022-01021-8","volume":"23","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S, Park CY. Pathogenic mechanisms in acute myeloid leukemia. Curr Treat Options Oncol. 2022;23(11):1522\u201334.","journal-title":"Curr Treat Options Oncol"},{"key":"3962_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/genes15010063","author":"Y Zhai","year":"2023","unstructured":"Zhai Y, Shen H, Wei H. A comprehensive metabolism-related gene signature predicts the survival of patients with acute myeloid leukemia. Genes. 2023. https:\/\/doi.org\/10.3390\/genes15010063.","journal-title":"Genes"},{"issue":"12","key":"3962_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. 2022;13(12):877\u2013919.","journal-title":"Protein Cell"},{"key":"3962_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.931527","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. The metabolic signature of AML cells treated with homoharringtonine. Front Oncol. 2022;12:931527.","journal-title":"Front Oncol"},{"key":"3962_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010253","author":"D Damiani","year":"2022","unstructured":"Damiani D, Tiribelli M. Present and future role of immune targets in acute myeloid leukemia. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers15010253.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"3962_CR13","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1182\/blood.2022018092","volume":"141","author":"SK Mishra","year":"2023","unstructured":"Mishra SK, Millman SE, Zhang L. Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets. Blood. 2023;141(10):1119\u201335.","journal-title":"Blood"},{"issue":"26","key":"3962_CR14","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1200\/JCO.2017.77.6112","volume":"36","author":"JE Lancet","year":"2018","unstructured":"Lancet JE, et al. CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia. J Clin Oncol. 2018;36(26):2684\u201392.","journal-title":"J Clin Oncol"},{"issue":"10","key":"3962_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrclinonc.2012.150","volume":"9","author":"JJ Cornelissen","year":"2012","unstructured":"Cornelissen JJ, et al. The european leukemiaNet AML working party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach. Nat Rev Clin Oncol. 2012;9(10):579\u201390.","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"3962_CR16","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136\u201352.","journal-title":"N Engl J Med"},{"key":"3962_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"RM Shallis","year":"2019","unstructured":"Shallis RM, et al. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70\u201387.","journal-title":"Blood Rev"},{"issue":"4","key":"3962_CR18","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/JCI129204","volume":"130","author":"L Vago","year":"2020","unstructured":"Vago L, Gojo I. Immune escape and immunotherapy of acute myeloid leukemia. J Clin Invest. 2020;130(4):1552\u201364.","journal-title":"J Clin Invest"},{"issue":"1","key":"3962_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-022-01528-6","volume":"21","author":"PR Pandey","year":"2022","unstructured":"Pandey PR, et al. RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics. Mol Cancer. 2022;21(1):58.","journal-title":"Mol Cancer"},{"issue":"7","key":"3962_CR20","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1158\/0008-5472.CAN-20-2352","volume":"81","author":"U Ghoshdastider","year":"2021","unstructured":"Ghoshdastider U, et al. Pan-cancer analysis of ligand-receptor cross-talk in the tumor microenvironment. Cancer Res. 2021;81(7):1802\u201312.","journal-title":"Cancer Res"},{"issue":"6","key":"3962_CR21","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ni.3412","volume":"17","author":"R Drissen","year":"2016","unstructured":"Drissen R, et al. Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing. Nat Immunol. 2016;17(6):666\u201376.","journal-title":"Nat Immunol"},{"issue":"1\u20132","key":"3962_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cell.2015.12.046","volume":"164","author":"F Paul","year":"2016","unstructured":"Paul F, et al. Transcriptional heterogeneity and lineage commitment in myeloid progenitors. Cell. 2016;164(1\u20132):325.","journal-title":"Cell"},{"issue":"6","key":"3962_CR23","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, et al. Single-Cell RNA-Seq reveals AML hierarchies relevant to disease progression and immunity. Cell. 2019;176(6):1265\u2013e128124.","journal-title":"Cell"},{"issue":"1","key":"3962_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13059-023-03031-7","volume":"24","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML. Genome Biol. 2023;24(1):199.","journal-title":"Genome Biol"},{"issue":"1","key":"3962_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13073-023-01241-z","volume":"15","author":"HL Mumme","year":"2023","unstructured":"Mumme HL, et al. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia. Genome Med. 2023;15(1):83.","journal-title":"Genome Med"},{"issue":"13","key":"3962_CR26","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573\u2013e358729.","journal-title":"Cell"},{"issue":"2","key":"3962_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372.","journal-title":"Nat Immunol"},{"issue":"3","key":"3962_CR28","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, et al. Clusterprofiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2(3):100141.","journal-title":"Innovation (Camb)"},{"issue":"12","key":"3962_CR29","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1109\/TVCG.2014.2346248","volume":"20","author":"A Lex","year":"2014","unstructured":"Lex A, et al. UpSet: visualization of intersecting sets. IEEE Trans Vis Comput Graph. 2014;20(12):1983\u201392.","journal-title":"IEEE Trans Vis Comput Graph"},{"issue":"12","key":"3962_CR30","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1074\/mcp.TIR120.002155","volume":"19","author":"J Griss","year":"2020","unstructured":"Griss J, et al. ReactomeGSA - efficient multi-omics comparative pathway analysis. Mol Cell Proteomics. 2020;19(12):2115\u201325.","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"3962_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, et al. Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level. Cancer Discov. 2022;12(1):134\u201353.","journal-title":"Cancer Discov"},{"issue":"1","key":"3962_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using cellchat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"4","key":"3962_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136.","journal-title":"Nat Biotechnol"},{"key":"3962_CR34","doi-asserted-by":"crossref","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. Bmj, 2021. 375: p. n2026.","DOI":"10.1136\/bmj.n2026"},{"key":"3962_CR35","doi-asserted-by":"crossref","unstructured":"Zhong F et al. m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia. Sci Rep, 2022. 12(1): p. 1759.","DOI":"10.1038\/s41598-022-05797-5"},{"key":"3962_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.722064","volume":"12","author":"C Dong","year":"2021","unstructured":"Dong C, Zhang N, Zhang L. The multi-omic prognostic model of oxidative stress-related genes in acute myeloid leukemia. Front Genet. 2021;12:722064.","journal-title":"Front Genet"},{"issue":"1","key":"3962_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","volume":"36","author":"S Tettamanti","year":"2022","unstructured":"Tettamanti S, et al. Catch me if you can: how AML and its niche escape immunotherapy. Leukemia. 2022;36(1):13\u201322.","journal-title":"Leukemia"},{"issue":"10","key":"3962_CR38","first-page":"937","volume":"84","author":"G Leone","year":"1999","unstructured":"Leone G, et al. The incidence of secondary leukemias. Haematologica. 1999;84(10):937\u201345.","journal-title":"Haematologica"},{"key":"3962_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.critrevonc.2016.04.020","volume":"103","author":"R Austin","year":"2016","unstructured":"Austin R, Smyth MJ, Lane SW. Harnessing the immune system in acute myeloid leukaemia. Crit Rev Oncol Hematol. 2016;103:62\u201377.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3962_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.biopha.2017.10.100","volume":"97","author":"DO Acheampong","year":"2018","unstructured":"Acheampong DO, et al. Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy. Biomed Pharmacother. 2018;97:225\u201332.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3962_CR41","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13045-017-0505-0","volume":"10","author":"FS Lichtenegger","year":"2017","unstructured":"Lichtenegger FS, et al. Recent developments in immunotherapy of acute myeloid leukemia. J Hematol Oncol. 2017;10(1):142.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"3962_CR42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","volume":"21","author":"AE Whiteley","year":"2021","unstructured":"Whiteley AE, et al. Leukaemia: a model metastatic disease. Nat Rev Cancer. 2021;21(7):461\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3962_CR43","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.immuni.2017.10.021","volume":"47","author":"A Y\u00e1\u00f1ez","year":"2017","unstructured":"Y\u00e1\u00f1ez A, et al. Granulocyte-Monocyte progenitors and Monocyte-Dendritic cell progenitors independently produce functionally distinct monocytes. Immunity. 2017;47(5):890\u2013e9024.","journal-title":"Immunity"},{"issue":"7","key":"3962_CR44","doi-asserted-by":"publisher","first-page":"e0288162","DOI":"10.1371\/journal.pone.0288162","volume":"18","author":"S Trova","year":"2023","unstructured":"Trova S, et al. Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation. PLoS One. 2023;18(7):e0288162.","journal-title":"PLoS One"},{"issue":"3","key":"3962_CR45","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/JLB.5AB1017-419RR","volume":"104","author":"DA Pollyea","year":"2018","unstructured":"Pollyea DA, et al. Monocyte function in patients with myelodysplastic syndrome. J Leukoc Biol. 2018;104(3):641\u20137.","journal-title":"J Leukoc Biol"},{"key":"3962_CR46","doi-asserted-by":"publisher","first-page":"155479","DOI":"10.1016\/j.cyto.2021.155479","volume":"142","author":"I Karagiannidis","year":"2021","unstructured":"Karagiannidis I, et al. G-CSF in tumors: aggressiveness, tumor microenvironment and immune cell regulation. Cytokine. 2021;142:155479.","journal-title":"Cytokine"},{"issue":"6","key":"3962_CR47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/MOH.0b013e32835903ab","volume":"19","author":"W Arcese","year":"2012","unstructured":"Arcese W, De Angelis G, Cerretti R. Granulocyte-mobilized bone marrow. Curr Opin Hematol. 2012;19(6):448\u201353.","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"3962_CR48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4103\/tcmj.tcmj_98_21","volume":"34","author":"HH Chang","year":"2022","unstructured":"Chang HH, Liou YS, Sun DS. Hematopoietic stem cell mobilization. Tzu Chi Med J. 2022;34(3):270\u20135.","journal-title":"Tzu Chi Med J"},{"issue":"2","key":"3962_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/14712598.2017.1269167","volume":"17","author":"F Baron","year":"2017","unstructured":"Baron F, Nagler A. Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy. Expert Opin Biol Ther. 2017;17(2):163\u201374.","journal-title":"Expert Opin Biol Ther"},{"key":"3962_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100850","volume":"50","author":"E O\u2019Reilly","year":"2021","unstructured":"O\u2019Reilly E, Zeinabad HA, Szegezdi E. Hematopoietic versus leukemic stem cell quiescence: challenges and therapeutic opportunities. Blood Rev. 2021;50:100850.","journal-title":"Blood Rev"},{"issue":"1","key":"3962_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/MOH.0000000000000105","volume":"22","author":"V Makaryan","year":"2015","unstructured":"Makaryan V, et al. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Curr Opin Hematol. 2015;22(1):3\u201311.","journal-title":"Curr Opin Hematol"},{"key":"3962_CR52","unstructured":"Dale DC, Makaryan V et al. ELANE-Related Neutropenia, in GeneReviews(\u00ae), M.P. Adam, Editors. 1993, University of Washington, Seattle Copyright \u00a9 1993\u20132024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.: Seattle (WA)."},{"issue":"8","key":"3962_CR53","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1074\/jbc.M116.755157","volume":"292","author":"Y Qiu","year":"2017","unstructured":"Qiu Y, et al. A truncated granulocyte colony-stimulating factor receptor (G-CSFR) inhibits apoptosis induced by neutrophil elastase G185R mutant: implication for understanding CSF3R gene mutations in severe congenital neutropenia. J Biol Chem. 2017;292(8):3496\u2013505.","journal-title":"J Biol Chem"},{"issue":"22","key":"3962_CR54","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1182\/blood.V128.22.1326.1326","volume":"128","author":"DC Dale","year":"2016","unstructured":"Dale DC, et al. Termination and frameshift mutations in ELANE are associated with adverse outcomes in patients with severe chronic neutropenia. Blood. 2016;128(22):1326\u20131326.","journal-title":"Blood"},{"issue":"21","key":"3962_CR55","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1182\/blood.V120.21.3275.3275","volume":"120","author":"V Makaryan","year":"2012","unstructured":"Makaryan V, et al. Clinical outcomes for patients with severe chronic neutropenia due to mutations in the gene for neutrophil elastase, ELANE. Blood. 2012;120(21):3275\u20133275.","journal-title":"Blood"},{"issue":"Supplement1","key":"3962_CR56","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1182\/blood-2019-127409","volume":"134","author":"B Garg","year":"2019","unstructured":"Garg B, et al. Inducible expression of mutant ELANE correlates with disruption of differentiation program, but not the unfolded protein response. Blood. 2019;134(Supplement1):103\u2013103.","journal-title":"Blood"},{"issue":"2","key":"3962_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100716","volume":"23","author":"RW Sprung","year":"2024","unstructured":"Sprung RW, et al. Stabilizing the proteomes of acute myeloid leukemia cells: implications for cancer proteomics. Mol Cell Proteomics. 2024;23(2):100716.","journal-title":"Mol Cell Proteomics"},{"key":"3962_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102256","volume":"50","author":"Z Xiao","year":"2022","unstructured":"Xiao Z, et al. Reduction of lactoferrin aggravates neuronal ferroptosis after intracerebral hemorrhagic stroke in hyperglycemic mice. Redox Biol. 2022;50:102256.","journal-title":"Redox Biol"},{"issue":"5","key":"3962_CR59","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1161\/STROKEAHA.117.020544","volume":"49","author":"X Zhao","year":"2018","unstructured":"Zhao X, et al. Beneficial role of neutrophils through function of lactoferrin after intracerebral hemorrhage. Stroke. 2018;49(5):1241\u20137.","journal-title":"Stroke"},{"issue":"8","key":"3962_CR60","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1038\/s41423-021-00718-4","volume":"18","author":"X Sun","year":"2021","unstructured":"Sun X, et al. PKM2 controls the degranulation of secondary and tertiary granules in neutrophils by phosphorylating SNAP-23. Cell Mol Immunol. 2021;18(8):2048\u201350.","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"3962_CR61","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1136\/jcp.36.12.1397","volume":"36","author":"J Miyauchi","year":"1983","unstructured":"Miyauchi J, et al. Lactoferrin-deficient neutrophil polymorphonuclear leucocytes in leukaemias: a semiquantitative and ultrastructural cytochemical study. J Clin Pathol. 1983;36(12):1397\u2013405.","journal-title":"J Clin Pathol"},{"issue":"2","key":"3962_CR62","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2141.1990.tb02562.x","volume":"74","author":"CE van der Schoot","year":"1990","unstructured":"van der Schoot CE, et al. Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia. Br J Haematol. 1990;74(2):173\u20138.","journal-title":"Br J Haematol"},{"issue":"2","key":"3962_CR63","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1600-0609.1987.tb01154.x","volume":"38","author":"G Oberg","year":"1987","unstructured":"Oberg G, et al. Diagnostic and prognostic significance of serum measurements of lactoferrin, lysozyme and myeloperoxidase in acute myeloid leukemia (AML): recognition of a new variant, high-lactoferrin AML. Eur J Haematol. 1987;38(2):148\u201355.","journal-title":"Eur J Haematol"},{"issue":"1","key":"3962_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40164-024-00479-6","volume":"13","author":"J Liu","year":"2024","unstructured":"Liu J, et al. Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, and drug resistance. Exp Hematol Oncol. 2024;13(1):12.","journal-title":"Exp Hematol Oncol"},{"key":"3962_CR65","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jconrel.2024.03.022","volume":"368","author":"ME Aikins","year":"2024","unstructured":"Aikins ME, et al. STING-activating cyclic dinucleotide-manganese nanoparticles evoke robust immunity against acute myeloid leukemia. J Control Release. 2024;368:768\u201379.","journal-title":"J Control Release"},{"key":"3962_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2024.113666","volume":"528","author":"H Tang","year":"2024","unstructured":"Tang H, et al. Simultaneous determination of inflammatory factors SAA and LTF based on stable element labeling and inductively coupled plasma mass spectrometry to aid in the diagnosis of infection. J Immunol Methods. 2024;528:113666.","journal-title":"J Immunol Methods"},{"issue":"1","key":"3962_CR67","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1038\/s41598-017-04275-7","volume":"7","author":"L Hu","year":"2017","unstructured":"Hu L, et al. Extraordinarily potent proinflammatory properties of lactoferrin-containing immunocomplexes against human monocytes and macrophages. Sci Rep. 2017;7(1):4230.","journal-title":"Sci Rep"},{"key":"3962_CR68","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fimmu.2020.00086","volume":"11","author":"R Lira-Junior","year":"2020","unstructured":"Lira-Junior R, et al. S100A12 expression is modulated during monocyte differentiation and reflects periodontitis severity. Front Immunol. 2020;11:86.","journal-title":"Front Immunol"},{"issue":"5","key":"3962_CR69","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1097\/01.CCM.0000262386.32287.29","volume":"35","author":"H Wittkowski","year":"2007","unstructured":"Wittkowski H, et al. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med. 2007;35(5):1369\u201375.","journal-title":"Crit Care Med"},{"key":"3962_CR70","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.lfs.2017.10.036","volume":"191","author":"A Nazari","year":"2017","unstructured":"Nazari A, et al. S100A12 in renal and cardiovascular diseases. Life Sci. 2017;191:253\u20138.","journal-title":"Life Sci"},{"issue":"1","key":"3962_CR71","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/s41598-020-58534-1","volume":"10","author":"X Wang","year":"2020","unstructured":"Wang X, et al. S100A12 is a promising biomarker in papillary thyroid cancer. Sci Rep. 2020;10(1):1724.","journal-title":"Sci Rep"},{"key":"3962_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23136952","author":"O Mitrovi\u0107 Ajti\u0107","year":"2022","unstructured":"Mitrovi\u0107 Ajti\u0107 O, et al. Regulation of S100As expression by inflammatory cytokines in chronic lymphocytic leukemia. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23136952.","journal-title":"Int J Mol Sci"},{"key":"3962_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/genes14101880","author":"RR Canevarolo","year":"2023","unstructured":"Canevarolo RR, Cury NM, Yunes JA. The expression and activation of the NF-\u03baB pathway correlate with methotrexate resistance and cell proliferation in acute lymphoblastic leukemia. Genes. 2023. https:\/\/doi.org\/10.3390\/genes14101880.","journal-title":"Genes"},{"issue":"8","key":"3962_CR74","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1111\/cas.15855","volume":"114","author":"J Lu","year":"2023","unstructured":"Lu J, et al. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6\/JAK2\/STAT3 signaling. Cancer Sci. 2023;114(8):3287\u2013300.","journal-title":"Cancer Sci"},{"issue":"1","key":"3962_CR75","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12964-023-01282-2","volume":"21","author":"M Bakhtiyari","year":"2023","unstructured":"Bakhtiyari M, et al. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways. Cell Commun Signal. 2023;21(1):252.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"3962_CR76","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/imm.13722","volume":"171","author":"P Xia","year":"2024","unstructured":"Xia P, et al. Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity. Immunology. 2024;171(3):365\u201376.","journal-title":"Immunology"},{"issue":"6","key":"3962_CR77","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1476-5381.1995.tb15892.x","volume":"115","author":"K Masuda","year":"1995","unstructured":"Masuda K, et al. Pharmacological activity of the C-terminal and N-terminal domains of secretory leukoprotease inhibitor in vitro. Br J Pharmacol. 1995;115(6):883\u20138.","journal-title":"Br J Pharmacol"},{"issue":"8","key":"3962_CR78","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1034\/j.1398-9995.1999.00938.x","volume":"54","author":"U Westin","year":"1999","unstructured":"Westin U, et al. The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, alpha1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge. Allergy. 1999;54(8):857\u201364.","journal-title":"Allergy"},{"key":"3962_CR79","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-2094-5-20","volume":"5","author":"AM Mueller","year":"2008","unstructured":"Mueller AM, et al. Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis. J Neuroinflammation. 2008;5:20.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"3962_CR80","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/1073858414546000","volume":"21","author":"SS Hannila","year":"2015","unstructured":"Hannila SS. Secretory leukocyte protease inhibitor (SLPI): emerging roles in CNS trauma and repair. Neuroscientist. 2015;21(6):630\u20136.","journal-title":"Neuroscientist"},{"issue":"1","key":"3962_CR81","doi-asserted-by":"publisher","first-page":"15550","DOI":"10.1038\/s41598-024-66400-7","volume":"14","author":"PL Azevedo","year":"2024","unstructured":"Azevedo PL, et al. SLPI overexpression in hMSCs could be implicated in the HSC gene expression profile in AML. Sci Rep. 2024;14(1):15550.","journal-title":"Sci Rep"},{"issue":"4","key":"3962_CR82","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12094-014-1232-4","volume":"17","author":"J Zuo","year":"2015","unstructured":"Zuo J, et al. Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells. Clin Transl Oncol. 2015;17(4):314\u201321.","journal-title":"Clin Transl Oncol"},{"key":"3962_CR83","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.2147\/OTT.S162407","volume":"11","author":"Q Ye","year":"2018","unstructured":"Ye Q, et al. Downregulation of PDIA3 inhibits proliferation and invasion of human acute myeloid leukemia cells. Onco Targets Ther. 2018;11:2925\u201335.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"3962_CR84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12915-019-0670-4","volume":"17","author":"L Stuani","year":"2019","unstructured":"Stuani L, Sabatier M, Sarry JE. Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia. BMC Biol. 2019;17(1):57.","journal-title":"BMC Biol"},{"issue":"6","key":"3962_CR85","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.cell.2014.07.048","volume":"158","author":"YH Wang","year":"2014","unstructured":"Wang YH, et al. Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis. Cell. 2014;158(6):1309\u201323.","journal-title":"Cell"},{"issue":"4","key":"3962_CR86","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ymgme.2020.05.005","volume":"130","author":"AV Wojcicki","year":"2020","unstructured":"Wojcicki AV, et al. Metabolomics in acute myeloid leukemia. Mol Genet Metab. 2020;130(4):230\u20138.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"3962_CR87","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0005-2760(97)00041-6","volume":"1346","author":"D Reynaud","year":"1997","unstructured":"Reynaud D, Pace-Asciak CR. Docosahexaenoic acid causes accumulation of free arachidonic acid in rat pineal gland and hippocampus to form hepoxilins from both substrates. Biochim Biophys Acta. 1997;1346(3):305\u201316.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"3962_CR88","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1600-0609.2007.00967.x","volume":"79","author":"G Runarsson","year":"2007","unstructured":"Runarsson G, et al. The expression of cytosolic phospholipase A2 and biosynthesis of leukotriene B4 in acute myeloid leukemia cells. Eur J Haematol. 2007;79(6):468\u201376.","journal-title":"Eur J Haematol"},{"issue":"11","key":"3962_CR89","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1167\/iovs.14-16291","volume":"56","author":"N Martinez-Gil","year":"2015","unstructured":"Martinez-Gil N, et al. CYP2E1 in the human retinal pigment epithelium: expression, activity, and induction by ethanol. Invest Ophthalmol Vis Sci. 2015;56(11):6855\u201363.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3962_CR90","first-page":"589","volume":"19","author":"YM Xi","year":"2011","unstructured":"Xi YM, et al. Relation of GSTP1 and CYP2E1 polymorphisms with susceptibility to acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011;19(3):589\u201393.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"9","key":"3962_CR91","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/sj.leu.2402572","volume":"16","author":"S Pillozzi","year":"2002","unstructured":"Pillozzi S, et al. HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia. 2002;16(9):1791\u20138.","journal-title":"Leukemia"},{"issue":"4","key":"3962_CR92","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s12015-021-10308-6","volume":"18","author":"NA Long","year":"2022","unstructured":"Long NA, et al. Acute myeloid leukemia stem cells: origin, characteristics, and clinical implications. Stem Cell Rev Rep. 2022;18(4):1211\u201326.","journal-title":"Stem Cell Rev Rep"},{"issue":"12","key":"3962_CR93","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/gcc.22805","volume":"58","author":"M Chopra","year":"2019","unstructured":"Chopra M, Bohlander SK. The cell of origin and the leukemia stem cell in acute myeloid leukemia. Genes Chromosomes Cancer. 2019;58(12):850\u20138.","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"3962_CR94","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/leu.2017.284","volume":"32","author":"MA Hospital","year":"2018","unstructured":"Hospital MA, et al. RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia. Leukemia. 2018;32(3):597\u2013605.","journal-title":"Leukemia"},{"key":"3962_CR95","doi-asserted-by":"publisher","first-page":"216779","DOI":"10.1016\/j.canlet.2024.216779","volume":"587","author":"S Chakraborty","year":"2024","unstructured":"Chakraborty S, et al. Molecular mechanisms in regulation of autophagy and apoptosis in view of epigenetic regulation of genes and involvement of liquid-liquid phase separation. Cancer Lett. 2024;587:216779.","journal-title":"Cancer Lett"},{"issue":"1","key":"3962_CR96","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/cdd.2017.169","volume":"25","author":"BJ Aubrey","year":"2018","unstructured":"Aubrey BJ, et al. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 2018;25(1):104\u201313.","journal-title":"Cell Death Differ"},{"key":"3962_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126380","author":"A Marszo\u0142ek","year":"2024","unstructured":"Marszo\u0142ek A, et al. Haploidentical HSCT in the treatment of pediatric hematological disorders. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25126380.","journal-title":"Int J Mol Sci"},{"issue":"Supplement 1","key":"3962_CR98","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1182\/blood-2018-99-110481","volume":"132","author":"C Aftandilian","year":"2018","unstructured":"Aftandilian C, et al. Chromatin remodeling therapy and Capizzi methotrexate in treatment-related MDS\/AML. Blood. 2018;132(Supplement 1):5222\u20135222.","journal-title":"Blood"},{"key":"3962_CR99","doi-asserted-by":"publisher","first-page":"838688","DOI":"10.3389\/fphar.2022.838688","volume":"13","author":"H Nie","year":"2022","unstructured":"Nie H, et al. Sivelestat alleviates atherosclerosis by improving intestinal barrier function and reducing endotoxemia. Front Pharmacol. 2022;13:838688.","journal-title":"Front Pharmacol"},{"issue":"11","key":"3962_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101295","volume":"4","author":"Y Wu","year":"2023","unstructured":"Wu Y, Yu XZ. Tipping the GVH\/GVL balance by targeting HIF1\u03b1. Cell Rep Med. 2023;4(11):101295.","journal-title":"Cell Rep Med"},{"issue":"6","key":"3962_CR101","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1007\/s10620-010-1520-y","volume":"56","author":"Y Araki","year":"2011","unstructured":"Araki Y, et al. Sivelestat suppresses iNOS gene expression in proinflammatory cytokine-stimulated hepatocytes. Dig Dis Sci. 2011;56(6):1672\u201381.","journal-title":"Dig Dis Sci"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03962-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03962-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03962-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:06:14Z","timestamp":1759493174000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03962-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3962"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03962-0","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human protocols were implemented strictly on the basis of the Ethical Guidelines of the Declaration of Helsinki and was approved by the ethics committee of the first people\u2019s hospital of Yunnan Province (No.: 2021YY192). Patients were acknowledged fully about the usage of the sample before the acquisition of samples, and informed consent was obtained by all the patience and\/or their guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"326"}}